Meg Jardine's Publications

• Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Adaptive Designs for Clinical Trials in Nephrology

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes

  Journal articles

  2024

  Journal of the American College of Cardiology

• Title: Vascular Endothelial Growth Factor (VEGF)-B Blockade with CSL346 in Diabetic Kidney Disease A Phase 2A Randomized Controlled Trial

  Journal articles

  2024

  Journal of the American Society of Nephrology

• Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial

  Journal articles

  2024

  European Journal of Heart Failure

• The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system

  Journal articles

  2024

  Peritoneal Dialysis International

• Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research

  Journal articles

  2024

  Canadian Journal of Kidney Health and Disease

• Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy

  Journal articles

  2024

  Kidney International Reports

• WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN

  Journal articles

  2024

  Kidney International Reports

• Effect of SGLT2 Inhibitors on Discontinuation of Reninangiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

  Journal articles

  2023

  Journal of the American Society of Nephrology

• Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial

  Journal articles

  2023

  Cardiovascular Diabetology

• Cystatin Cbased estimated glomerular filtration rate and risk of stroke in the general population: a prospective cohort study

  Journal articles

  2023

  Clinical Kidney Journal

• Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2023

  Kidney International

• Duration and effectiveness of glucose-lowering regimens in the real world management of diabetes: Data from the Australian EXTEND45 Linked Cohort Study

  Journal articles

  2023

  Endocrine and Metabolic Science

• Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Journal articles

  2023

  Kidney International

• Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study

  Journal articles

  2023

  European Heart Journal - Quality of Care and Clinical Outcomes

• The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials

  Journal articles

  2023

  Diabetes, Obesity and Metabolism

• Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

  Journal articles

  2023

  Journal of the American Heart Association

• A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

  Journal articles

  2023

  Nature Medicine

• Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada

  Journal articles

  2023

  Kidney Medicine

• Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

  Journal articles

  2023

  American Journal of Kidney Diseases

• Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

  Journal articles

  2023

  BMJ Open Diabetes Research and Care

• The impact of dexmedetomidine on postoperative delirium: should we throw out a DECADE of research?

  Journal articles

  2023

  British Journal of Anaesthesia

• Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial

  Journal articles

  2023

  Clinical journal of the American Society of Nephrology : CJASN

• Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

  Journal articles

  2023

  The Lancet

• Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial

  Journal articles

  2023

  Diabetes, Obesity and Metabolism